Taysha Gene Therapies
TSHA
TSHA
48 hedge funds and large institutions have $388M invested in Taysha Gene Therapies in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
26
Reduced
5
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$62.9M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
$9.16M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
$14.5M |
| 4 |
State Street
Boston,
Massachusetts
|
$6.76M |
| 5 |
JPMorgan Chase & Co
New York
|
$4.53M |
